Outlook Therapeutics (OTLK) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Outlook Therapeutics (OTLK) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Outlook Therapeutics

· OTLK

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

152.325 M

-8.34%

General

Market Cap: $152.33M
Enterprise Value: $114.43M
Shares Outstanding: 187,000,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -233.43%
ROE: 222.01%
ROIC: -343.68%
Current Ratio: 0.81
Debt-to-Equity: -1.77
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -1.84

Growth

Rev 1Y: —
Rev 1Y Fwd Est: 45.88%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): -12.24%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: -$1.16M
Gross Margin: —
Operating Expenses: $53.36M
Operating Income: -$55.64M
Net Profit: -$61.12M

Balance Sheet

Cash and Equivalents: $11.24M
Working Capital: -$5.51M
Total Assets: $26.18M
Net Debt: $7.19M
Total Liabilities: $36.58M
Total Equity: -$10.39M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$57.13M
Cash Flow from Investing: -$2.1M
Cash Flow from Financing: $61.57M
Free Cash Flow: -$57.13M
Capital Expenditures: -$2